Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- NPO to Be Inaugurated to Promote Self-medication
April 29, 2002
- Kusuri Proverbs Reveal Japanese Spirit (8)
April 29, 2002
- Drug Terashima: Sales Up to \37,883 Mil.
April 29, 2002
- 8 NCEs Including Infliximab Included in NHI Price List
April 29, 2002
- Showa Denko Develops Anesthetic Waste Gas Disposal System
April 29, 2002
- Applicants' Sales Forecasts for New Drugs Announced by Korosho
April 29, 2002
- MEDICAL DEVICE NEWS IN BRIEF
April 29, 2002
- Korosho Invites Opinions on Its Vision from Industry
April 29, 2002
- Becton Dickinson Proposes Safe, Efficient Lab Testing Centers
April 29, 2002
- BULLETIN
April 29, 2002
- Eli Lilly Asked to Distribute Dear-Doctor Letter on Zyprexa
April 29, 2002
- Sysmex: New Blood Cell Analyzer XT-2000i
April 29, 2002
- Competition Intensifies on Market for Antidepressants
April 29, 2002
- Companies' Responsibility for Promotion of Medical Safety Clarified
April 29, 2002
- We Are Open to Strategic Alliance: Mr Wright of AstraZeneca
April 29, 2002
- Eisai to Apply for Vascular Dementia for Aricept in US
April 29, 2002
- REGULATORY NEWS IN BRIEF
April 29, 2002
- Mr Nordhoff Talks about Prospects of Gen-Probe
April 29, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
April 29, 2002
- PhRMA Japan Representative Discusses AIDS in Developing Countries
April 29, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…